Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Fosamprenavir
DRUG: Lopinavir/Ritonavir
DRUG: Ritonavir
DRUG: Tenofovir disoproxil fumarate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)